NORCURON Side Effects

6669811-6 | Breath Holding, Bronchospasm, Increased Bronchial Secretion
on Mar 26, 2010 Female patient from INDIA , 29 years of age, was treated with Norcuron (View Usage). Patient experienced the following unwanted or unexpected effects: breath holding, bronchospasm, increased bronchial secretion. Norcuron dosage: Iv. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ).

6592992-X | Anaphylactic Shock
Patient was taking Norcuron (View Usage). Patient had the following side effects: anaphylactic shock on Jan 29, 2010 from FRANCE Additional patient health information: Female patient , 83 years of age, . Norcuron dosage: 5 Mg; Once; Iv. During the same period patient was treated with CEFAMANDOLE (CEFAMANDOLE) (750 Mg; Once; Iv) (View Cefamandole (cefamandole) Review and Cefamandole (cefamandole) Label ), ETOMIDATE (24 Mg; Once; Iv) (View Etomidate Review and Etomidate Label ), SUFENTANIL CITRATE (5 Mcg; Once; Iv) (View Sufentanil Citrate Review and Sufentanil Citrate Label ), CORGARD (View Corgard Review and Corgard Label ).

6592879-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Liver Injury, Post Procedural Complication
Adverse event was reported on Jan 18, 2010 by a Female patient taking Norcuron (View Usage) (Dosage: ) . Location: AUSTRALIA , 80 years of age, weighting 130.1 lb, After Norcuron was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver injury, post procedural complication. During the same period patient was treated with GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), METRAMINOL TARTATE (METARAMINOL TARTRATE) (View Metraminol Tartate (metaraminol Tartrate) Review and Metraminol Tartate (metaraminol Tartrate) Label ), ONDANSETRON HYDROCHLORIDE DIHYDRATE (ONDANSETRON HYDROCHLORIDE) (View Ondansetron Hydrochloride Dihydrate (ondansetron Hydrochloride) Review and Ondansetron Hydrochloride Dihydrate (ondansetron Hydrochloride) Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

6580246-7 | Anaphylactic Shock, Circulatory Collapse
on Jan 29, 2010 Female patient from FRANCE , 83 years of age, was treated with Norcuron (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, circulatory collapse. Norcuron dosage: 5 Mg; Once; Iv. During the same period patient was treated with CEFAMANDOLE (CEFAMANDOLE) (750 Mg; Once; Iv) (View Cefamandole (cefamandole) Review and Cefamandole (cefamandole) Label ), ETOMIDATE (24 Mg; Once; Iv) (View Etomidate Review and Etomidate Label ), SUFENTANIL CITRATE (5 Mcg; Once; Iv) (View Sufentanil Citrate Review and Sufentanil Citrate Label ), CORGARD (View Corgard Review and Corgard Label ).


6565872-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Liver Injury
on Jan 18, 2010 Female patient from AUSTRALIA , 80 years of age, weighting 130.1 lb, was treated with Norcuron (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver injury. Norcuron dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), METARAMINOL BITARTRATE (View Metaraminol Bitartrate Review and Metaraminol Bitartrate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ), PARACETAMOL /00020001/ (PARACETAMOL /00020001/) (View Paracetamol /00020001/ (paracetamol /00020001/) Review and Paracetamol /00020001/ (paracetamol /00020001/) Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

6552916-8 | Anaphylactic Shock
Patient was taking Norcuron (View Usage). After Norcuron was administered, patient had the following side effects: anaphylactic shock on Jan 19, 2010 from FRANCE Additional patient health information: Female patient , 84 years of age, . Norcuron dosage: Once;iv. During the same period patient was treated with CEFAMNDOLE (CEFAMANDOLE) (Once;iv) (View Cefamndole (cefamandole) Review and Cefamndole (cefamandole) Label ).

6542829-X | Anaphylactic Shock
Adverse event was reported on Jan 05, 2010 by a Female patient taking Norcuron (View Usage) (Dosage: Once; Iv) . Location: FRANCE , 84 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock. During the same period patient was treated with CEFAMANDOLE (CEFAMANDOLE) (Once; Iv) (View Cefamandole (cefamandole) Review and Cefamandole (cefamandole) Label ).

6327728-0 | Fear, Paralysis Flaccid, Respiratory Arrest
on Aug 07, 2009 Male patient from UNITED STATES , child 3 years of age, was treated with Norcuron (View Usage). Patient had the following side effects: fear, paralysis flaccid, respiratory arrest. Norcuron dosage: Once;. During the same period patient was treated with SALINE (View Saline Review and Saline Label ).

5708751-3 | Asthma, Prolonged Expiration
on Apr 02, 2008 Female patient from JAPAN , 49 years of age, was diagnosed with induction of anaesthesia and was treated with Norcuron (View Usage). After Norcuron was administered, patient had the following side effects: asthma (What is asthma?), prolonged expiration. Norcuron dosage: 1.5 Mg/kg Once Intravenous (nos). During the same period patient was treated with MIDAZOLAM HCL (0.1 Mg/kg Once Intravenous (nos)) (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL CITRATE (0.5 Ug/kg Once Intravenous (nos)) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ).